Haematology, immunology & rare diseases

Difexa

Deferasirox

Dispersible tablets Made in Medjez El Bab GMP-certified site
INN
Deferasirox
Dosage form
Dispersible tablets
Therapeutic area
Haematology, immunology & rare diseases
Indications
Indicated for: - Treatment of transfusional haemosiderosis. - Treatment of chronic iron overload requiring chelation therapy in patients aged 10 years and older with non-transfusion-dependent thalassaemia.

Presentations

PresentationStrengthPack size
Difexa125mgBox of 30
Difexa250mgBox of 30
Difexa500mgBox of 28

Information intended for healthcare professionals. Prescription-only medicine in accordance with current regulations: read the package leaflet carefully. Translation provided for information only. Only the package leaflet approved in the country of marketing is authoritative.